Slow release theophylline in preschool asthmatics

Area of Science:

• Pediatric Pulmonology
• Clinical Pharmacology

Background:

• Asthma is a common chronic respiratory disease in young children.
• Wheezing in preschool children presents diagnostic and management challenges.
• Theophylline has been used for asthma, but its efficacy in very young children requires evaluation.

Purpose of the Study:

• To evaluate the efficacy of slow-release theophylline (Slo-phyllin) in preschool children with asthma.
• To compare active treatment with placebo using a double-blind crossover design.
• To assess the utility of symptom scores as a measure of clinical improvement in this age group.

Main Methods:

• A double-blind, placebo-controlled crossover trial was conducted.
• Participants were children aged up to 4 years diagnosed with asthma.
• Patients received either slow-release theophylline or a placebo in a randomized sequence.

Main Results:

• No significant difference was observed in overall symptom scores between the active treatment and placebo groups.
• However, other clinical indicators favored the active theophylline treatment.
• The study highlights potential benefits beyond standard symptom scoring.

Conclusions:

• Slow-release theophylline (Slo-phyllin) demonstrates benefit in managing wheezing preschool children with asthma.
• The preparation is a valuable option for this patient population.
• The study discusses the limitations of symptom scores in assessing clinical improvement in young asthmatic children.